These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2352989)

  • 21. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus nephritis: therapeutic decisions.
    Hahn BH
    Hosp Pract (Off Ed); 1990 Mar; 25(3A):89-93, 96-7, 103-4. PubMed ID: 2108180
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lupus nephritis with nephrotic syndrome successfully treated with plasmapheresis and cyclophosphamide].
    Obroniecka I; Korsak J; Wańkowicz Z
    Pol Arch Med Wewn; 1994 Mar; 91(3):227-31. PubMed ID: 8029131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recovery of kidney function in a female patient with severe lupus nephropathy].
    Hernández Marrero D; Torres Ramírez A; Méndez Medina R; González-Posada JM; Losada Cabrera M; Lorenzo Sellares V; Maceira Cruz B
    An Med Interna; 1989 Apr; 6(4):209-11. PubMed ID: 2491524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of lupus nephritis in childhood].
    Ghio L; Edefonti A; Cohen E; Giani M; Miglioli E; Bardare M
    Pediatr Med Chir; 1986; 8(3):325-8. PubMed ID: 3786194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide for severe lupus nephritis: where are we now?
    Mok CC
    Arthritis Rheum; 2004 Dec; 50(12):3748-50. PubMed ID: 15593210
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.
    Sugimoto K; Yamaji K; Yang KS; Kanai Y; Tsuda H; Hashimoto H
    Ther Apher Dial; 2006 Apr; 10(2):187-92. PubMed ID: 16684222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and intensive treatment of lupus nephritis with pulse cyclophosphamide.
    Gandhi R
    J Assoc Physicians India; 1993 Feb; 41(2):101. PubMed ID: 8335598
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lupus erythematosus; current treatment methods].
    Nossent JC
    Ned Tijdschr Geneeskd; 1993 Mar; 137(11):558. PubMed ID: 8464532
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of LED-nephritis].
    Mustonen J
    Duodecim; 1994; 110(11):1090-5. PubMed ID: 7588119
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy.
    Hussein MM; Mooij JM; Roujouleh H
    Clin Nephrol; 1993 Sep; 40(3):160-3. PubMed ID: 8403571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():13-8. PubMed ID: 12583308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.
    Derksen RH; Hené RJ; Kallenberg CG; Valentijn RM; Kater L
    Neth J Med; 1988 Oct; 33(3-4):168-77. PubMed ID: 3067098
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study.
    Lachin JM; Lan SP
    Control Clin Trials; 1992 Feb; 13(1):62-79. PubMed ID: 1315665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apheresis in lupus nephritis.
    Mistry-Burchardi N; Schönermarck U; Samtleben W
    Ther Apher; 2001 Jun; 5(3):161-70. PubMed ID: 11467751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.